MedPath

Effect of ciprofol combined with sufentanil on anesthesia awakening time, Steward awakening score and adverse effects of painless bronchoscopy: a clinical study

Phase 4
Recruiting
Conditions
Quality of perioperative awakening
Registration Number
ChiCTR2300071785
Lead Sponsor
The First Affiliated Hospital of University of Science and Technology of China
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  1. Age 18-75 years old, gender unlimited;<br>2. ASA grade is I-II;<br>3. 18 kg/m2 <= BMI <= 30kg/m2;<br>4. Subjects who plan to undergo bronchoscopic diagnosis and/or treatment with laryngeal mask ventilation;<br>5. Able to understand and voluntarily sign an informed consent form (ICF), willing to comply with and expected to complete the test according to the requirements of the test protocol.
Exclusion Criteria
  1. Persons with a contraindication to deep sedation/general anesthesia or a history of previous sedation/anesthesia accidents;<br>2. Those who are allergic to or contraindicated to benzodiazepines, opioids, propofol, flumazenil, naloxone, lidocaine, and their drug components;<br>3. Those who have undergone tracheal intubation and/or mechanical ventilation prior to bronchoscopic consultation;<br>4. Those with combined severe cardiovascular, respiratory, or neurological diseases that are not well controlled;<br>5. Those whose laboratory tests are not indicative;<br>6. Those with a modified marsupial score of grade III or higher;<br>7. History of substance abuse, drug abuse, alcoholism, and long-term psychotropic drug use within 1 year prior to the start of the screening period. Alcohol abuse defined as regular alcohol consumption more than 14 times/week (1 time = 150 mL of wine or 360 mL of beer or 45 mL of spirits);<br>8. Pregnant or breastfeeding women;<br>9. Those who participated in any clinical trial (including drug or device clinical trials) as a subject within 1 month prior to enrollment;<br>10. Other conditions that are determined by the investigator to be unsuitable for enrollment.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Grading of anesthetic effects;awakening time;Steward score ;
Secondary Outcome Measures
NameTimeMethod
Adverse reactions;Adverse reactions;
© Copyright 2025. All Rights Reserved by MedPath